Skip to content

Effects of Chiropractic on Chronic Cancer-related Fatigue

The Effects of Upper Cervical Chiropractic Care in Adult Cancer Survivors With Chronic Cancer-related Fatigue: a Feasibility Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06235671
Acronym
CAN
Enrollment
20
Registered
2024-02-01
Start date
2024-03-01
Completion date
2024-12-31
Last updated
2024-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Fatigue

Keywords

cancer survivors, upper cervical chiropractic, manipulation, cancer-related fatigue, autonomic nervous system

Brief summary

The primary aims of the proposed trial are centered around examining the feasibility of conducting a prospective, chiropractic intervention study on a population of cancer survivors living in and around Atlanta, Georgia. This includes evaluating various implementation outcomes including recruitment, adherence, tolerability, retention, acceptability, and data fidelity. The results of this trial will inform the design of a future randomized controlled trial (RCT) that has an increased focus on the efficacy/effectiveness of chiropractic care on chronic cancer-related fatigue (CCRF) and other cancer-related sequelae in cancer survivors.

Detailed description

Cancer remission is often marked by the cessation of curative-intent treatments (e.g., surgery, chemotherapy, radiotherapy, immunotherapy), however, troublesome signs and symptoms (e.g., fatigue, depression, cognitive impairment, dysautonomia) related to the cancer and its treatments commonly persist for prolonged periods (i.e., months to years). Of these, chronic cancer-related fatigue (CCRF) is one of the most frequently reported and debilitating symptoms. CCRF may be characterized as tiredness or exhaustion persisting for 3 or more months following the completion of the primary curative-intent cancer therapies which is independent on one's quantity or quality of rest and causes impairments in daily functioning and quality of life. Notably, although the mechanisms underlying CCRF are still unclear, there is some evidence that it may be related to autonomic dysregulation. Irrespective of the cause(s), lack of identification of and treatment for CCRF and other chronic cancer-related sequelae is commonplace. Further, empirical data supporting the efficacy of interventions to remediate these issues are relatively sparse and urgently needed as the global population of cancer survivors continues to increase. Of note, although there is no universally accepted definition of 'cancer survivor', the investigators define it here as someone who has completed their primary curative-intent therapies and is cancer-free (i.e., has no evidence of active disease). This definition is in line with that of the European Organisation of Research & Treatment of Cancer (EORTC) Survivorship Task Force and the EORTC Quality of Life Group. Interestingly, a recent study suggested that a single chiropractic adjustment may mitigate lower extremity muscular fatigue during isometric exercise in young, healthy males. However, to the investigators' knowledge, the impact of chiropractic care on CCRF and other health-related challenges that burden cancer survivors has yet to be investigated.

Interventions

6 weeks of chiropractic care

Sponsors

Life University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single-arm feasibility trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Able to understand and provide written informed consent in English * 18-65 years of age * Informed by primary health care provider that there is no evidence of active disease (this is sometimes referred to as complete remission or cured) * Minimum of 3 months since completion of primary curative-intent cancer therapies including surgery, chemotherapy, radiotherapy, and/or immunotherapy (long-term hormonal therapy permitted) * Onset of fatigue occurred at some point during illness and/or treatment * FACIT-Fatigue scale score in the moderate-to-severe range (i.e., at or above the 60th percentile) * If on any prescription medication (including hormonal therapy), on a stable dose for a minimum of 12 weeks with no plans to change medications or doses during the study

Exclusion criteria

* Taking any short-acting benzodiazepine including midazolam & triazolam * Known disorder resulting in syncope/fainting during postural changes (e.g., postural orthostatic tachycardia syndrome, orthostatic hypotension) * Pacemaker or known heart condition that influences the electrical or mechanical function of the heart (e.g., severe heart valve disease) * Diagnosed with an externalizing (e.g., substance use, antisocial disorder) or thought (e.g., schizophrenia, paranoid personality, bipolar) disorder that is uncontrolled or untreated * Diagnosed with rheumatoid arthritis, osteoporosis, or cervical spine instability * Currently pregnant * Current litigation related to a physical, health-related injury * Chronic pain rated at least 3/10 on a visual analog scale (VAS)

Design outcomes

Primary

MeasureTime frameDescription
Participant recruitment6-month data collection periodAverage number of participants recruited/enrolled per month
Participant scheduling6-month data collection periodAverage time lag between first lab assessment & first chiropractic visit
Participant compliance6-month data collection periodProportion of participants violating 1 or more pre-assessment lifestyle restrictions & unable/unwilling to be rescheduled
Participant adherence6-month data collection periodProportion of participants not attending at least 80% of their chiropractic sessions
Participant tolerability6-month data collection periodProportion of participants unable/unwilling to complete a given assessment
Participant retention6-month data collection periodProportion of participants completing the trial
Assessment acceptability6-month data collection periodMost common patient-related acceptability score for each assessment process/procedure
Data fidelity6-month data collection periodProportion of acquisitions from a given assessment that are unsuitable for analysis
Implementation acceptability6-month data collection periodMost common clinician-rated acceptability score for each trial process/procedure

Countries

United States

Contacts

Primary ContactAustin Garlinghouse
research.studies@life.edu770-426-2639

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026